Texas hospitals expect to lose $27 million a day in Medicaid funding
When the state’s new fiscal year begins on Tuesday, Texas hospitals expect to lose $27 million a day…
This medical device stock looks like a gift for patient investors
Insulet is a high-quality compounder where a temporary execution issue is masking strong underlying fundamentals. Type 2 diabetes…
Trump strikes new drug pricing deals with nine midsized drugmakers
U.S. President Donald Trump delivers remarks on his administration’s healthcare policies, in the Oval Office at the White…
Lilly to buy Merida Biosciences for up to $2.88 billion in autoimmune drug push
Eli Lilly and Company’s logo is displayed during a press conference in Houston, Texas, U.S., Sept. 23, 2025.…
BioCryst is profitable. Now it wants to buy more rare disease drugs
CNBC Cures is proudly underwritten by Alexion, AstraZeneca Rare Disease, whose support enables our journalism to elevate stories…
FDA approves Gilead HIV pill Bixlenvo designed to simplify treatment
Gilead Bixlenvo drug Courtesy: Gilead The Food and Drug Administration approved a once-daily HIV pill from Gilead that…
Revolution Medicines gets FDA nod for targeted pancreatic cancer drug
Menta “Steve” Wallace shows a bottle of daraxonrasib, Revolution Medicines’ pancreatic cancer drug, at his home in The…
BioMarin to acquire Alesta Therapeutics for $275 million
Piotr Swat | Lightrocket | Getty Images CNBC Cures is proudly underwritten by Alexion, AstraZeneca Rare Disease, whose…
After a layoff and long job search, this 45-year-old is going to nursing school
Kristy Layden was tired of opening LinkedIn and seeing one person after another post about being laid off…
The startup using AI to help build custom treatments for rare diseases
Jacalyn Lee, founder of The DAND Alliance, and her youngest daughter Isla. Jacalyn Lee CNBC Cures is proudly…
How Nevada made big strides to keep kids with behavioral health issues out of institutions
State officials announced a “dramatic drop” in the number of children with behavioral health disabilities who have been…
Jazz Pharmaceuticals to buy Actio Biosciences for $820 million
Piotr Swat | Lightrocket | Getty Images CNBC Cures is proudly underwritten by Alexion, AstraZeneca Rare Disease, whose…